[1]
|
Zhao L, Chen L, Yang T, et al. Birth prevalence of congenital heart disease in China, 1980—2019: a systematic review and meta-analysis of 617 studies[J]. Eur J Epidemiol, 2020, 35: 631-642. doi: 10.1007/s10654-020-00653-0 |
[2]
|
中国生物医学工程学会体外循环分会. 2019年中国心外科手术和体外循环数据白皮书[J]. 中国体外循环杂志, 2020, 18: 193-196. https://www.cnki.com.cn/Article/CJFDTOTAL-TWXH202004001.htm |
[3]
|
Rashkind WJ, Miller WW. Creation of an atrial septal defect without thoracotomy. A palliative approach to complete transposition of the great arteries[J]. JAMA, 1966, 196: 991-992. doi: 10.1001/jama.1966.03100240125026 |
[4]
|
钱晋卿, 华仰德, 姜宏兰. 导管栓塞法关闭动脉导管14例体会[J]. 中华医学杂志, 1986, 66: 751-753. doi: 10.3760/j:issn:0376-2491.1986.12.021 |
[5]
|
张伟华, 任森根. 采用Sideris钮扣装置经导管治疗左向右分流先天性心脏病8例报告[J]. 重庆医学, 1996, 25: 266-267. https://www.cnki.com.cn/Article/CJFDTOTAL-CQYX199605003.htm |
[6]
|
蒋世良, 戴汝平, 赵世华. 应用Amplatzer封堵器治疗动脉导管未闭[J]. 中华放射学杂志, 1999, 33: 745. doi: 10.3760/j.issn:1005-1201.1999.11.007 |
[7]
|
夏呈森, 朱卫华. 国产球囊导管经皮扩张成形术治疗小儿先天性肺动脉瓣狭窄30例报告[J]. 临床儿科杂志, 1993, 11: 96-98. https://www.cnki.com.cn/Article/CJFDTOTAL-LCAK199302014.htm |
[8]
|
蒋世良, 金敬琳, 徐仲英, 等. 采用10F国产球囊导管介入治疗体重≥10 kg儿童肺动脉瓣狭窄[J]. 中国介入心脏病学杂志, 2014, 22: 545-548. doi: 10.3969/j.issn.1004-8812.2014.09.001 |
[9]
|
秦永文, 胡建强, 赵仙先. 自制镍钛合金室间隔缺损封堵器的生物相容性研究[J]. 第二军医大学学报, 2001, 22: 1038-1040. doi: 10.3321/j.issn:0258-879X.2001.11.014 |
[10]
|
秦永文, 赵仙先, 李卫萍, 等. 应用自制封堵器经导管闭合膜部室间隔缺损[J]. 介入放射学杂志, 2002, 11: 130-131. doi: 10.3969/j.issn.1008-794X.2002.02.021 |
[11]
|
秦永文, 吴弘, 赵仙先, 等. 膜部瘤型室间隔缺损的介入治疗[J]. 介入放射学杂志, 2006, 15: 6-9. https://www.cnki.com.cn/Article/CJFDTOTAL-JRFS200601002.htm |
[12]
|
秦永文, 赵仙先, 吴弘, 等. 自制非对称型室间隔缺损封堵器的初步临床应用[J]. 介入放射学杂志, 2004, 13: 101-103. https://www.cnki.com.cn/Article/CJFDTOTAL-JRFS200402002.htm |
[13]
|
Qin Y, Chen J, Zhao X, et al. Transcatheter closure of perimembranous ventricular septal defect using a modified double-disk occluder[J]. Am J Cardiol, 2008, 101: 1781-1786. doi: 10.1016/j.amjcard.2008.02.069 |
[14]
|
Bai Y, Xu XD, Li CY, et al. Complete atrioventricular block after percutaneous device closure of perimembranous ventricular septal defect: A single-center experience on 1046 cases[J]. Heart Rhythm, 2015, 12: 2132-2140. doi: 10.1016/j.hrthm.2015.05.014 |
[15]
|
Apostolopoulou SC, Tsoutsinos A, Laskari C, et al. Large single centre experience with the CeraTM and CeraFlexTM occluders for closure of interatrial communications: usefulness of the flexible rotation feature[J]. Cardiovasc Interv Ther, 2018, 33: 70-76. doi: 10.1007/s12928-016-0440-y |
[16]
|
Sievert K, Yu J, Bertog S, et al. Post-market clinical follow-up with the patent foramen ovale closure device IrisFIT (Lifetech) in patients with stroke, transient ischemic attack or other thromboembolic events[J]. Cardiovasc Revasc Med, 2020: S1553-8389(20)30581-9. doi: 10.1016/j.carrev.2020.09.031. |
[17]
|
宣斌, 秦永文, 胡建强, 等. 双侧无铆型房间隔缺损封堵器的实验研究[J]. 介入放射学杂志, 2006, 15: 683-685. https://www.cnki.com.cn/Article/CJFDTOTAL-JRFS200611014.htm |
[18]
|
郑纯风. Parylene涂层封堵器在先天性心脏病治疗中的效果评价[J]. 中国医学装备, 2016: 91-94. https://www.cnki.com.cn/Article/CJFDTOTAL-YXZB201604030.htm |
[19]
|
周勇, 张磊, 赵先仙, 等. 涤纶膜外套式镍钛合金室间隔缺损封堵器的制作[J]. 第二军医大学学报, 2012, 33: 1335-1338. https://www.cnki.com.cn/Article/CJFDTOTAL-DEJD201212014.htm |